tradingkey.logo

cbdMD Inc

YCBD
0.923USD
-0.040-4.21%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
8.23MMarktkapitalisierung
VerlustKGV TTM

cbdMD Inc

0.923
-0.040-4.21%

mehr Informationen über cbdMD Inc Unternehmen

cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.

cbdMD Inc Informationen

BörsenkürzelYCBD
Name des UnternehmenscbdMD Inc
IPO-datumNov 17, 2017
CEOKennedy (T. Ronan)
Anzahl der mitarbeiter42
WertpapierartOrdinary Share
GeschäftsjahresendeNov 17
Addresse8845 Red Oak Blvd
StadtCHARLOTTE
BörseNASDAQ OMX – NASDAQ Basic Amex
LandUnited States of America
Postleitzahl28217-5593
Telefon17044453060
Websitehttps://www.cbdmd.com/
BörsenkürzelYCBD
IPO-datumNov 17, 2017
CEOKennedy (T. Ronan)

Führungskräfte von cbdMD Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Scott G. Stephen
Mr. Scott G. Stephen
Independent Chairman of the Board
Independent Chairman of the Board
1.83K
-393.00%
Mr. Bakari T. Sellers
Mr. Bakari T. Sellers
Independent Director
Independent Director
1.75K
-373.00%
Mr. William F. Raines, III
Mr. William F. Raines, III
Independent Director
Independent Director
--
--
Mr. T. Ronan Kennedy
Mr. T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
--
--
Dr. Sibyl Swift
Dr. Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
--
--
Mr. Bradley Whitford
Mr. Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Chief Accounting Officer, Treasurer, Company Secretary
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Scott G. Stephen
Mr. Scott G. Stephen
Independent Chairman of the Board
Independent Chairman of the Board
1.83K
-393.00%
Mr. Bakari T. Sellers
Mr. Bakari T. Sellers
Independent Director
Independent Director
1.75K
-373.00%
Mr. William F. Raines, III
Mr. William F. Raines, III
Independent Director
Independent Director
--
--
Mr. T. Ronan Kennedy
Mr. T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
--
--
Dr. Sibyl Swift
Dr. Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
--
--
Mr. Bradley Whitford
Mr. Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Chief Accounting Officer, Treasurer, Company Secretary
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
E-commerce sales
14.72M
76.68%
Wholesale sales
4.48M
23.32%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
E-commerce sales
14.72M
76.68%
Wholesale sales
4.48M
23.32%

Aktionärsstatistik

Aktualisiert: Mon, Feb 2
Aktualisiert: Mon, Feb 2
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Porter (Jeffrey H)
5.48%
Crc Investment Fund LP
4.16%
CSS, LLC
1.36%
The Vanguard Group, Inc.
0.94%
Chapin Davis Asset Management
0.77%
Andere
87.30%
Aktionäre
Aktionäre
Anteil
Porter (Jeffrey H)
5.48%
Crc Investment Fund LP
4.16%
CSS, LLC
1.36%
The Vanguard Group, Inc.
0.94%
Chapin Davis Asset Management
0.77%
Andere
87.30%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
6.43%
Investment Advisor
4.22%
Corporation
4.16%
Investment Advisor/Hedge Fund
0.13%
Andere
85.06%

Institutionelle Beteiligung

Aktualisiert: Wed, Jan 21
Aktualisiert: Wed, Jan 21
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q4
33
436.16K
5.38%
--
2025Q4
53
457.02K
4.35%
-122.38K
2025Q3
51
502.25K
5.64%
+188.29K
2025Q2
61
1.71M
19.14%
+1.55M
2025Q1
80
154.62K
3.22%
-19.13K
2024Q4
76
811.68K
23.02%
+42.15K
2024Q3
80
869.63K
30.51%
+134.84K
2024Q2
85
734.40K
27.03%
-50.91K
2024Q1
91
757.62K
28.39%
-18.50K
2023Q4
95
764.16K
29.72%
+83.63K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Porter (Jeffrey H)
73.26K
0.78%
+73.26K
--
May 16, 2025
Crc Investment Fund LP
436.15K
4.63%
-797.41K
-64.64%
Dec 17, 2025
CSS, LLC
142.62K
1.51%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
51.56K
0.55%
+51.56K
--
Sep 30, 2025
Chapin Davis Asset Management
121.55K
1.29%
+2.92K
+2.47%
Sep 30, 2025
Kennedy (Thomas Ronan)
454.31K
4.82%
+445.00K
+4778.27%
Nov 28, 2025
Alesco Advisors LLC
68.51K
0.73%
--
--
Sep 30, 2025
Roe (Kevin Charles)
4.52K
0.05%
+4.52K
--
May 16, 2025
Commonwealth Financial Network
16.25K
0.17%
--
--
Sep 30, 2025
Scientech Research LLC
15.41K
0.16%
+15.41K
--
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Cambria Cannabis ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Amplify Seymour Cannabis ETF
0%
Cambria Cannabis ETF
Anteil0%
iShares Core S&P Total U.S. Stock Market ETF
Anteil0%
Amplify Seymour Cannabis ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Apr 21, 2025
Merger
8→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Datum
Ex-Dividendentag
Art
Verhältnis
Apr 21, 2025
Merger
8→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
KeyAI